JTCS Concomitant Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Article

J Thorac Cardiovasc Surg 2006;132:1279
© 2006 The American Association for Thoracic Surgery

Surgery for Congenital Heart Disease

Discussion

The first 20% of the full text of this article appears below.

Dr Frank W. Sellke (Boston, Mass). This is a very nice in vitro study of the effects of overexpression of ILK on cardiac stem cell growth.

I have a couple questions. Was the purpose of this study just to increase expansion of the stem cell population, or do you think that it perhaps could overcome some of the negative influences of ischemia, diabetes, and similar issues on stem cell engraftment and function?

Second, do you have any evidence from in vivo studies that this will be translated into a physiologic or potentially a clinical benefit?

Finally, how . . . [Full Text of this Article]


Related Article

Overexpression of integrin-linked kinase induces cardiac stem cell expansion
Hideaki Yamabi, Huanzhang Lu, Xiaojing Dai, Yanruo Lu, Gregory Hannigan, and John G. Coles
J. Thorac. Cardiovasc. Surg. 2006 132: 1272-1279. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The American Association for Thoracic Surgery.